Sponsor
Mironid Limited
John Arbuthnott Building, 161 Cathedral Street, G4 0RE, United Kingdom
About the sponsor
Mironid Limited focuses on clinical research in autosomal dominant polycystic kidney disease, a hereditary disorder characterised by progressive kidney enlargement and loss of renal function. Its activity is centred on therapies relevant to cystic kidney disease and the underlying mechanisms that drive renal deterioration.
- Autosomal dominant polycystic kidney disease
- Inherited renal disorders
- Progressive kidney disease
The sponsor’s research interest lies in treatment areas associated with renal function preservation and disease-specific intervention for patients affected by hereditary kidney conditions.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.